Articles citing this paper
Moving beyond the rhetoric of patient input in health technology assessment deliberations
Sally Wortley A E , Janet Wale B , David Grainger C and Peter Murphy D
+ Author Affiliations
- Author Affiliations
A Sydney School of Public Health, The University of Sydney, Camperdown, NSW 2006, Australia.
B 11A Lydia Street, Brunswick, Vic. 3056, Australia. Email: socrates111@bigpond.com
C Eli Lilly and Company, 112 Wharf Road, Melrose Park, NSW 2114, Australia. Email: grainger_david@lilly.com
D Novartis, 54 Waterloo Road, Macquarie Park, Sydney, NSW 2113, Australia. Email: peter.murphy@novartis.com
E Corresponding author. Email: sally.wortley@sydney.edu.au
Australian Health Review 41(2) 170-172 https://doi.org/10.1071/AH15216
Submitted: 10 November 2015 Accepted: 1 April 2016 Published: 26 May 2016
10 articles found in Crossref database.
Patient advocate perspectives on involvement in HTA: an international snapshot
Scott Anna Mae, Wale Janet L.
Research Involvement and Engagement. 2017 3(1).
Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups
Mercer Rebecca E.,
Chambers Alexandra,
Mai Helen,
McDonald Valerie,
McMahon Carole, Chan Kelvin K.W.
Value in Health. 2020 23(9). p.1157
Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?
Ghinea Narcyz,
Lipworth Wendy, Kerridge Ian
Journal of Bioethical Inquiry. 2020 17(1). p.87
Patient preferences for breast cancer treatments: a discrete choice experiment in France, Ireland, Poland and Spain
Stamuli Eugena,
Corry Sorcha,
Ross Derek,
Konstantopoulou Thomais,
Texeira Luis,
Avouac Bernard,
Debiais Dominique,
Yates Liz,
Behis Arni,
McLoughlin Ambrose,
Stowarzyszeń Amazonki Federacja,
Niewada Maciej,
Casas Ana, Espin Jaime
Future Oncology. 2022 18(9). p.1115
Patients’ Associations and HTA for medicines: actual and future role in Italy
Jommi Claudio, Bertolani Arianna
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish. 2018 2018 p.228424031877096
What Is Next for Patient Preferences in Health Technology Assessment? A Systematic Review of the Challenges
Huls Samare P.I.,
Whichello Chiara L.,
van Exel Job,
Uyl-de Groot Carin A., de Bekker-Grob Esther W.
Value in Health. 2019 22(11). p.1318
Value to Whom? The Patient Voice in the Value Discussion
Perfetto Eleanor M.,
Oehrlein Elisabeth M.,
Boutin Marc,
Reid Sarah, Gascho Eric
Value in Health. 2017 20(2). p.286
Ética y evaluación de tecnologías sanitarias. Revisión
García-León FJ.
Journal of Healthcare Quality Research. 2019 34(1). p.20
Patient advocacy group involvement in health technology assessments: an observational study
Single Ann,
Cabrera Ariana,
Fifer Simon,
Tsai Jane,
Paik Jin-Young, Hope Philip
Research Involvement and Engagement. 2021 7(1).
What does meaningful look like? A qualitative study of patient engagement at the Pan-Canadian Oncology Drug Review: perspectives of reviewers and payers
Rozmovits Linda,
Mai Helen,
Chambers Alexandra, Chan Kelvin
Journal of Health Services Research & Policy. 2018 23(2). p.72
